{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T12:56:29Z","timestamp":1776603389955,"version":"3.51.2"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Archives of Gerontology and Geriatrics"],"published-print":{"date-parts":[[2001,11]]},"DOI":"10.1016\/s0167-4943(01)00184-4","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T16:58:29Z","timestamp":1027616309000},"page":"219-226","source":"Crossref","is-referenced-by-count":27,"title":["Stroke prevention in atrial fibrillation: physicians\u2019 attitudes to anticoagulation in older people"],"prefix":"10.1016","volume":"33","author":[{"given":"Sanjeev","family":"Vasishta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farooque","family":"Toor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antony","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mujtaba","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0167-4943(01)00184-4_BIB1","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1136\/bmj.307.6911.1045","article-title":"Survey of use of anticoagulation in patients with atrial fibrillation","volume":"307","author":"Bath","year":"1993","journal-title":"Br. Med. J."},{"key":"10.1016\/S0167-4943(01)00184-4_BIB2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/01.CIR.84.2.527","article-title":"The stroke prevention in atrial fibrillation investigators. stroke prevention in atrial fibrillation study. Final results","volume":"84","author":"Cohen","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/S0167-4943(01)00184-4_BIB3","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/S0140-6736(94)92620-4","article-title":"The atrial fibrillation investigators. stroke prevention in atrial fibrillation II study","volume":"343","author":"Conolly","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/S0167-4943(01)00184-4_BIB4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0735-1097(91)90585-W","article-title":"Canadian Atrial Fibrillation Anticoagulation (CAFA) study","volume":"18","author":"Conolly","year":"1991","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/S0167-4943(01)00184-4_BIB5","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJM199211123272002","article-title":"Warfarin in the prevention of stroke associated with non-rheumatic atrial fibrillation. veterans affairs stroke prevention in non rheumatic atrial fibrillation investigators","volume":"327","author":"Ezekowitz","year":"1992","journal-title":"New Engl. J. Med."},{"key":"10.1016\/S0167-4943(01)00184-4_BIB6","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archinte.1994.00420130036007","article-title":"Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of anti-thrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomised controlled trials","volume":"154","author":"Laupacis","year":"1994","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/S0167-4943(01)00184-4_BIB7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/bmj.312.7022.45","article-title":"Antithrombotic treatment for atrial fibrillation","volume":"312","author":"Lip","year":"1996","journal-title":"Br. Med. J."},{"key":"10.1016\/S0167-4943(01)00184-4_BIB8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/archinte.1995.00430030071008","article-title":"Physician attitudes about anticoagulation for non valvular atrial fibrillation in the elderly","volume":"155","author":"McCrory","year":"1995","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/S0167-4943(01)00184-4_BIB9","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/j.1532-5415.1997.tb05967.x","article-title":"Physician attitudes concerning warfarin for stroke prevention in atrial fibrillation: results of a survey of long-term care practitioners","volume":"45","author":"Monette","year":"1997","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/S0167-4943(01)00184-4_BIB10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(89)91200-2","article-title":"Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study","volume":"1","author":"Peterson","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/S0167-4943(01)00184-4_BIB11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2141.1999.01174.x","article-title":"Final consensus statement of the Royal College of Physicians of Edinburgh consensus conference on atrial fibrillation in hospital and general practice, 3\u20134 September 1998","volume":"104","year":"1999","journal-title":"Br. J. Haematol."},{"key":"10.1016\/S0167-4943(01)00184-4_BIB12","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1056\/NEJM199011293232201","article-title":"The effect of low dose warfarin on the risk of stroke in patients with non-rheumatic atrial fibrillation. The Boston area anticoagulation trial for atrial fibrillation investigators","volume":"323","author":"Singer","year":"1990","journal-title":"New Engl. J. Med."},{"key":"10.1016\/S0167-4943(01)00184-4_BIB13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/ageing\/27.3.285","article-title":"The effect of age and quality of life on doctors\u2019 decision to anticoagulate patients with atrial fibrillation","volume":"27","author":"Sudlow","year":"1998","journal-title":"Age Ageing"},{"key":"10.1016\/S0167-4943(01)00184-4_BIB14","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1212\/WNL.28.10.973","article-title":"Epidemiologic assessment of chronic atrial fibrillation and risk of stroke. The Framingham study","volume":"28","author":"Wolf","year":"1978","journal-title":"Neurology"},{"key":"10.1016\/S0167-4943(01)00184-4_BIB15","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/archinte.1987.00370090041008","article-title":"Atrial fibrillation: a major contributor to stroke in the elderly","volume":"147","author":"Wolf","year":"1987","journal-title":"Arch. Intern. Med."}],"container-title":["Archives of Gerontology and Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167494301001844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167494301001844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T11:52:30Z","timestamp":1556193150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167494301001844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,11]]}},"alternative-id":["S0167494301001844"],"URL":"https:\/\/doi.org\/10.1016\/s0167-4943(01)00184-4","relation":{},"ISSN":["0167-4943"],"issn-type":[{"value":"0167-4943","type":"print"}],"subject":[],"published":{"date-parts":[[2001,11]]}}}